Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsSecuritiesSecurities - Held-to-maturitySecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metropolitan Bank Holding (MCB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Metropolitan Bank Holding (MCB) over the last 6 years, with Q3 2025 value amounting to $385.9 million.

  • Metropolitan Bank Holding's Cash & Equivalents rose 2118.14% to $385.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $385.9 million, marking a year-over-year increase of 2118.14%. This contributed to the annual value of $200.3 million for FY2024, which is 2567.94% down from last year.
  • As of Q3 2025, Metropolitan Bank Holding's Cash & Equivalents stood at $385.9 million, which was up 2118.14% from $152.5 million recorded in Q2 2025.
  • In the past 5 years, Metropolitan Bank Holding's Cash & Equivalents ranged from a high of $2.4 billion in Q4 2021 and a low of $152.5 million during Q2 2025
  • In the last 5 years, Metropolitan Bank Holding's Cash & Equivalents had a median value of $318.5 million in 2024 and averaged $724.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 17297.66% in 2021, then tumbled by 8908.95% in 2022.
  • Over the past 5 years, Metropolitan Bank Holding's Cash & Equivalents (Quarter) stood at $2.4 billion in 2021, then tumbled by 89.09% to $257.4 million in 2022, then grew by 4.68% to $269.5 million in 2023, then fell by 25.68% to $200.3 million in 2024, then soared by 92.71% to $385.9 million in 2025.
  • Its Cash & Equivalents stands at $385.9 million for Q3 2025, versus $152.5 million for Q2 2025 and $196.5 million for Q1 2025.